Active Screening of Arterial Hypertension by Community Outreach Workers in

Status Not yet recruiting

Clinical Trial Summary

The main objective is to implement of a community-based primary care intervention against high blood pressure. We want to show that this intervention decreases the incidence of stroke in the community of agglomerations of the central coast of French Guiana, with a rapid effectiveness of about -30% at 2 years.

Clinical Trial Description

The hypothesis of the research is that, thanks to a strategy of early detection of hypertension based on "outreach" by community relays, it will be possible to increase the effectiveness of primary prevention among the precarious population (early treatment, access to healthcare, improvement of therapeutic follow-up, reduction of renunciations and interruptions of treatment). This strategy, adapted to the Guianese context, would make it possible to reduce the incidence and mortality of cardiovascular diseases among the most vulnerable people, particularly stroke. Such data would be a prerequisite for a more ambitious strategy, aiming to implement policies on a sufficient scale policies on a scale and intensity sufficient to have an impact on the problem of social inequalities in health other than those related to high blood pressure. The quasi-experimental before-and-after methodology makes it possible to compare, on a population basis, a quantitative endpoint - in this case the number of strokes - between before and after the implementation of a public health intervention. For reasons of acceptance by the partners, statistical power, and potential bias, a before-and-after design seems more interesting. It will be a pre-screening of hypertension, a possible referral for medical care or opening of health care rights and health education through hygienic and dietary advice and health prevention focused on hypertension. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05814068
Study type	Interventional
Source	Centre Hospitalier de Cayenne
Contact	Mathieu NACHER, PhD
Phone	+594594395385
Email	mathieu.nacher@ch-cayenne.fr
Status	Not yet recruiting
Phase	N/A
Start date	May 1, 2023
Completion date	August 1, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03812614` - Comparative Effectiveness of Family vs. Individually Focused Diabetes Education and Support	N/A
Completed	`NCT03650166` - High BP and Home Monitoring Experience (HoME) Study	N/A
Recruiting	`NCT02908139` - Noninvasive Perioperative Monitoring of Arterial Stiffness, Volume and Nutritional Status in Stable Renal Transplant Recipients	N/A
Completed	`NCT01622400` - Efficacy of a Dedicated Therapeutic Education Program in Patients at High Cardiovascular Risk	N/A
Completed	`NCT00659672` - Effect of Whey Protein on Blood Pressure	N/A
Completed	`NCT00473681` - Intervention Study to Control High Blood Pressure for Korean American	N/A
Completed	`NCT03542240` - Effects of Curcumin Supplementation on Gut Barrier Function in Patients With Metabolic Syndrome	N/A
Active, not recruiting	`NCT05526092` - OAT-GUT-BRAIN: Effects of Oats and Rice on Comprehensive Health of Metabolically Challenged Individuals	N/A
Completed	`NCT02218931` - ESTEEM - Effect of Simple, Targeted Diet in Pregnant Women With Metabolic Risk Factors on Pregnancy Outcomes	N/A
Recruiting	`NCT03753204` - Salt-Sensitivity and Immunity Cell Activation	Phase 1/Phase 2
Completed	`NCT04479384` - The Immediate Effect of an Osteopathic Manual Treatment on Blood Pressure in Adults With Hypertension - a Pilot Study.	N/A
Not yet recruiting	`NCT04064281` - The Healthy Cantonese Diet on Cardiometabolic Syndrome	N/A
Completed	`NCT04082819` - MediBeat - HeartBeat Observation Trial	N/A
Completed	`NCT03555344` - Effect of Mantra on Hypertensive Patients	N/A
Withdrawn	`NCT03319823` - Treating Nocturnal Hypertension and Nocturia in African American Men	Phase 4
Completed	`NCT00689819` - Pre-clinical Cardiac Dysfunction Among Asymptomatic Hypertensive Patients	N/A
Completed	`NCT00417170` - Comparison of Aliskiren and Amlodipine on Insulin Resistance and Endothelial Dysfunction in Patients With Hypertension and Metabolic Syndrome	Phase 2
Completed	`NCT00130156` - Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential Hypertension	Phase 4
Completed	`NCT05808556` - Sticker Pad Containing Essential Oil in Volunteer With High Blood Pressure	N/A
Recruiting	`NCT05321368` - A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Active Screening of Arterial Hypertension by Community Outreach Workers in the Cayenne Metropolitan Area to Reduce the Incidence of Cardiovascular Disease

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms